DNAJC5 and pancreatic neoplasm: The elimination half-life (T1/2) ranged from 5 to 22 h across patients.<h4>Conclusion</h4>PTP-01 imaging of pancreatic tumors revealed the ability of a targeted agent to bind to CSP.